Literature DB >> 824439

Effects of propranolol on behavior maintained under fixed-ratio schedules of cocaine injection or food presentation in squirrel monkeys.

S R Goldberg, F A Gonzalez.   

Abstract

Behavior of squirrel monkeys was maintained under comparable 30-response fixed-ratio schedules of cocaine injection or fooc presentation. Every 30th key press in the presence of a green light produced an intravenous injection of 25 mug/kg of cocaine in one group of monkeys or delivery of a food pellet in a second group of monkeys. Each cocaine injection or food presentation was followed by a 1-minute timeout period, during which the green light was absent and responses had no programmed consequences. Responding at a mean rate of more than 1/sec was maintained in the presence of the green light during each daily session. Propranolol doses from 0.3 to 3.0 mg/kg i.m. had no effect on food-maintained responding but decreased cocaine-maintained responding by approximately 30%. The selective disruption of cocaine-maintained responding by propranolol appeared to depend on the cumulative cocaine dose. Decreases in cocaine-maintained responding after propranolol became increasingly pronounced as the session progressed. Similar progressive decreases in cocaine-maintained responding were produced by increasing the dose of cocaine per injection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 824439

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  The Roles of Dopamine and α1-Adrenergic Receptors in Cocaine Preferences in Female and Male Rats.

Authors:  Adam N Perry; Christel Westenbroek; Lakshmikripa Jagannathan; Jill B Becker
Journal:  Neuropsychopharmacology       Date:  2015-04-22       Impact factor: 7.853

2.  Alpha 1-noradrenergic system role in increased motivation for cocaine intake in rats with prolonged access.

Authors:  Sunmee Wee; Chitra D Mandyam; Dusan M Lekic; George F Koob
Journal:  Eur Neuropsychopharmacol       Date:  2007-10-24       Impact factor: 4.600

3.  Effects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats.

Authors:  Nicholas W Gilpin; George F Koob
Journal:  Psychopharmacology (Berl)       Date:  2010-07-31       Impact factor: 4.530

4.  Low-dose prazosin alone and in combination with propranolol or naltrexone: effects on ethanol and sucrose seeking and self-administration in the P rat.

Authors:  Terril L Verplaetse; Cristine L Czachowski
Journal:  Psychopharmacology (Berl)       Date:  2015-03-07       Impact factor: 4.530

5.  Cocaine, d-amphetamine, and pentobarbital effects on responding maintained by food or cocaine in rhesus monkeys.

Authors:  S Herling; D A Downs; J H Woods
Journal:  Psychopharmacology (Berl)       Date:  1979-09       Impact factor: 4.530

Review 6.  Psychostimulants affect dopamine transmission through both dopamine transporter-dependent and independent mechanisms.

Authors:  Ike Dela Peña; Ruzanna Gevorkiana; Wei-Xing Shi
Journal:  Eur J Pharmacol       Date:  2015-07-21       Impact factor: 4.432

Review 7.  Norepinephrine at the nexus of arousal, motivation and relapse.

Authors:  Rodrigo A España; Brooke E Schmeichel; Craig W Berridge
Journal:  Brain Res       Date:  2016-01-07       Impact factor: 3.252

8.  S(-)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats.

Authors:  Richard Young; Richard A Glennon
Journal:  Psychopharmacology (Berl)       Date:  2008-09-16       Impact factor: 4.530

Review 9.  Adrenaline rush: the role of adrenergic receptors in stimulant-induced behaviors.

Authors:  Karl T Schmidt; David Weinshenker
Journal:  Mol Pharmacol       Date:  2014-02-05       Impact factor: 4.436

Review 10.  Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.

Authors:  Paul W Czoty; William W Stoops; Craig R Rush
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.